Richard E. Chipkin

1.7k total citations
52 papers, 1.3k citations indexed

About

Richard E. Chipkin is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Richard E. Chipkin has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cellular and Molecular Neuroscience, 30 papers in Molecular Biology and 20 papers in Physiology. Recurrent topics in Richard E. Chipkin's work include Receptor Mechanisms and Signaling (23 papers), Neuropeptides and Animal Physiology (20 papers) and Pain Mechanisms and Treatments (17 papers). Richard E. Chipkin is often cited by papers focused on Receptor Mechanisms and Signaling (23 papers), Neuropeptides and Animal Physiology (20 papers) and Pain Mechanisms and Treatments (17 papers). Richard E. Chipkin collaborates with scholars based in United States, Sweden and Denmark. Richard E. Chipkin's co-authors include Louis C. Iorio, Vicki L. Coffin, A Barnett, Joel G. Berger, Tony L. Yaksh, Allen Barnett, Robert D. McQuade, Patricia OʼConnor, Richard McQuade and Ruth A. Duffy and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and Pain.

In The Last Decade

Richard E. Chipkin

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard E. Chipkin United States 21 856 559 328 173 162 52 1.3k
I.F. Tulloch Netherlands 21 973 1.1× 519 0.9× 404 1.2× 188 1.1× 88 0.5× 41 1.6k
R. Lofthouse United Kingdom 19 448 0.5× 939 1.7× 187 0.6× 146 0.8× 290 1.8× 29 1.7k
Suzanne Knapp United States 19 707 0.8× 390 0.7× 184 0.6× 129 0.7× 207 1.3× 43 1.4k
J E Leysen Belgium 13 1.2k 1.4× 920 1.6× 208 0.6× 90 0.5× 282 1.7× 20 1.8k
P Seeman Canada 17 841 1.0× 583 1.0× 102 0.3× 185 1.1× 367 2.3× 30 1.4k
Y. Claustre France 22 1.1k 1.3× 682 1.2× 150 0.5× 244 1.4× 322 2.0× 32 1.7k
Libby M. Yunger United States 20 763 0.9× 523 0.9× 200 0.6× 183 1.1× 129 0.8× 26 1.6k
Martin D. Hynes United States 19 863 1.0× 542 1.0× 328 1.0× 80 0.5× 130 0.8× 48 1.2k
Valérie Compan France 21 853 1.0× 539 1.0× 180 0.5× 210 1.2× 78 0.5× 39 1.4k
Vicki L. Coffin United States 21 998 1.2× 676 1.2× 98 0.3× 211 1.2× 211 1.3× 41 1.4k

Countries citing papers authored by Richard E. Chipkin

Since Specialization
Citations

This map shows the geographic impact of Richard E. Chipkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Chipkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Chipkin more than expected).

Fields of papers citing papers by Richard E. Chipkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Chipkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Chipkin. The network helps show where Richard E. Chipkin may publish in the future.

Co-authorship network of co-authors of Richard E. Chipkin

This figure shows the co-authorship network connecting the top 25 collaborators of Richard E. Chipkin. A scholar is included among the top collaborators of Richard E. Chipkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard E. Chipkin. Richard E. Chipkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilbert, Donald L., Tanya K. Murphy, Joseph Jankovic, et al.. (2018). Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo‐controlled crossover study. Movement Disorders. 33(8). 1272–1280. 50 indexed citations
2.
Torres, Rosa J., et al.. (2016). A double-blind, placebo-controlled, crossover trial of the selective dopamine D1 receptor antagonist ecopipam in patients with Lesch-Nyhan disease. Molecular Genetics and Metabolism. 118(3). 160–166. 22 indexed citations
3.
Sattler, Rita, et al.. (2011). Human nasal olfactory epithelium as a dynamic marker for CNS therapy development. Experimental Neurology. 232(2). 203–211. 17 indexed citations
4.
Duffy, Ruth A., G Kamińska, Richard E. Chipkin, & Robert D. McQuade. (1992). Selective up-regulation of D-1 dopamine receptors following chronic administration of SCH 39166 in primates. Pharmacology Biochemistry and Behavior. 41(1). 235–238. 8 indexed citations
5.
Tedford, Clark E., Gordon Crosby, Louis C. Iorio, & Richard E. Chipkin. (1992). Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices. European Journal of Pharmacology. 211(2). 169–176. 17 indexed citations
6.
McQuade, Richard, Ruth A. Duffy, Vicki L. Coffin, Richard E. Chipkin, & A Barnett. (1991). In vivo binding of SCH 39166: a D-1 selective antagonist.. Journal of Pharmacology and Experimental Therapeutics. 257(1). 42–49. 32 indexed citations
7.
McQuade, Robert D., Ruth A. Duffy, Gordon Crosby, et al.. (1991). [3H]SCH 39166, A New D1‐Selective Radioligand: In Vitro and In Vivo Binding Analyses. Journal of Neurochemistry. 57(6). 2001–2010. 32 indexed citations
8.
Chipkin, Richard E. & Vicki L. Coffin. (1991). Analgesic and acute central nervous system side effects of the intravenously administered enkephalinase inhibitor SCH 32615. Pharmacology Biochemistry and Behavior. 38(1). 21–27. 19 indexed citations
9.
10.
Al-Rodhan, Nayef R. F., Richard E. Chipkin, & Tony L. Yaksh. (1990). The antinociceptive effects of SCH-32615, a neutral endopeptidase (enkephalinase) inhibitor, microinjected into the periaqueductal, ventral medulla and amygdala. Brain Research. 520(1-2). 123–130. 55 indexed citations
11.
Yaksh, Tony L. & Richard E. Chipkin. (1989). Studies on the effect of SCH-34826 and thiorphan on [Met5]enkephalin levels and release in rat spinal cord. European Journal of Pharmacology. 167(3). 367–373. 22 indexed citations
12.
13.
Chipkin, Richard E.. (1988). Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats. Pharmacology Biochemistry and Behavior. 30(3). 683–686. 30 indexed citations
14.
McQuade, Robert D., et al.. (1988). Serotonergic component of SCH 23390: In vitro and in vivo binding analyses. Life Sciences. 43(23). 1861–1869. 62 indexed citations
15.
Chipkin, Richard E., et al.. (1988). Characterization of the radioiodinated analogue of SCH 23390: In vitro and in vivo D-1 dopamine receptor binding studies. Life Sciences. 43(14). 1151–1160. 20 indexed citations
16.
Chipkin, Richard E., Louis C. Iorio, Vicki L. Coffin, et al.. (1988). Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.. Journal of Pharmacology and Experimental Therapeutics. 247(3). 1093–1102. 150 indexed citations
17.
Barnett, Allen, Louis C. Iorio, Robert D. McQuade, & Richard E. Chipkin. (1988). Pharmacological and Behavioral Effects of D1 Dopamine Antagonists. Advances in experimental medicine and biology. 235. 137–144. 12 indexed citations
18.
Chipkin, Richard E., Robert D. McQuade, & Louis C. Iorio. (1987). D1 and D2 dopamine binding site up-regulation and apomorphine-induced stereotypy. Pharmacology Biochemistry and Behavior. 28(4). 477–482. 42 indexed citations
19.
Chipkin, Richard E., et al.. (1982). Potentiation of stress-induced analgesia (SIA) by thiorphan and its block by naloxone. Life Sciences. 31(12-13). 1189–1192. 31 indexed citations
20.
Stewart, John M., et al.. (1980). Inhibition of development of tolerance to morphine by a peptide related to ACTH.. PubMed. 22. 305–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I.F. Tulloch Breakdown of academic impact, for papers by R. Lofthouse Breakdown of academic impact, for papers by Suzanne Knapp Breakdown of academic impact, for papers by J E Leysen Breakdown of academic impact, for papers by P Seeman Breakdown of academic impact, for papers by Y. Claustre Breakdown of academic impact, for papers by Libby M. Yunger Breakdown of academic impact, for papers by Martin D. Hynes Breakdown of academic impact, for papers by Valérie Compan Breakdown of academic impact, for papers by Vicki L. Coffin
Rankless by CCL
2026